Stock Events

Stock Events

FluoGuide A/S 

SEK38.7
9
+SEK2.9+8.1% Friday 15:06

Statistics

Day High
42.1
Day Low
35.3
52W High
47.6
52W Low
28
Volume
20,025
Avg. Volume
7,948
Mkt Cap
527.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.85
-0.52
-0.18
0.15
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-89.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FLUO.ST. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
NovoCure
NVCR
Mkt Cap1.2B
NovoCure operates in the oncology field, focusing on tumor treating fields which competes with Fluoguide's targeted cancer therapies.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical offers robotic-assisted surgical systems, potentially competing with Fluoguide's guided surgery technologies.
Medtronic
MDT
Mkt Cap111.22B
Medtronic provides medical technologies, including surgical solutions that could compete with Fluoguide's precision oncology products.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation offers a range of medical devices that could be used in cancer treatments, competing with Fluoguide's solutions.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation specializes in medical technologies, including surgical equipment and navigation systems, which could compete with Fluoguide's guided surgery technologies.
Globus Medical
GMED
Mkt Cap11.89B
Globus Medical develops musculoskeletal solutions, including tools that could be used in surgical oncology, potentially competing with Fluoguide.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. offers surgical solutions, including technologies that could be applied in oncology, competing with Fluoguide's focus.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie is involved in biopharmaceuticals, including oncology, which could compete with Fluoguide's cancer targeting treatments.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson operates in various healthcare sectors, including oncology through its pharmaceutical and medical devices divisions, competing with Fluoguide's technologies.

About

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment of brain cancer through photothermal and photodynamic therapies. It has a collaboration agreement with Olympus and ZEISS Medical Technologies for the development of FG001 for tumor imaging and surgical margins assessment for head and neck cancer. The company was incorporated in 2018 and is based in Copenhagen, Denmark.
Show more...
CEO
Mr. Morten Albrechtsen B.B.A., M.D.
Employees
6
Country
SE
ISIN
DK0061123312

Listings

F
DE
96X.F
ST
SE
FLUO.ST

0 Comments

Share your thoughts

FAQ

What is FluoGuide A/S stock price today?▼
The current price of FLUO.ST is SEK38.7 SEK — it has increased by +8.1% in the past 24 hours. Watch FluoGuide A/S stock price performance more closely on the chart.
What is FluoGuide A/S stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange FluoGuide A/S stocks are traded under the ticker FLUO.ST.
Is FluoGuide A/S stock price growing?▼
FLUO.ST stock has risen by +2.65% compared to the previous week, the month change is a +22.08% rise, over the last year FluoGuide A/S has showed a -5.38% decrease.
What is FluoGuide A/S market cap?▼
Today FluoGuide A/S has the market capitalization of 527.09M
What is FluoGuide A/S revenue for the last year?▼
FluoGuide A/S revenue for the last year amounts to 0 SEK.
What is FluoGuide A/S net income for the last year?▼
FLUO.ST net income for the last year is -89.04M SEK.
How many employees does FluoGuide A/S have?▼
As of April 11, 2026, the company has 6 employees.
In which sector is FluoGuide A/S located?▼
FluoGuide A/S operates in the Health Care sector.
When did FluoGuide A/S complete a stock split?▼
FluoGuide A/S has not had any recent stock splits.
Where is FluoGuide A/S headquartered?▼
FluoGuide A/S is headquartered in Copenhagen, SE.